Biocon’s CEO & MD Siddharth Mittal speaks to Business Today about the company’s growth outlook, major product launches, and global expansion plans. From biosimilars leadership and generics growth to GLP-1 ambitions, Mittal shares how Biocon is gearing up for the next wave of opportunities in India and overseas.
2026 Investment Strategy: IT, Metal, Auto & Banking In Focus
Why Capital Market Stocks Should Be In Your 2026 Portfolio
PVR INOX MD Ajay Bijli On Movie Business In India
Digital Arrests, Fake Cops, Vanishing Crores: Inside India’s Exploding Cyber Fraud Crisis
RBI Rate Cuts To Drive Realty Stocks Higher In 2026, Here's The Top Picks
